JUUL Wants to Promote Itself as a Quit-Smoking Product
Description
JUUL Labs has launched a program to promote partnerships with businesses and
managed healthcare and insurance companies to offer JUUL products to employees
who want to quit smoking.
According to a story published by CNBC, Smok the San Francisco-based vape company is building an “enterprise markets team,” led by former Cardinal Health executive Douglas Roberts, who was hired by JUUL last year. The team has 17 employees so far.
Roberts told CNBC he has spent several months meeting with employers in the public and private sectors. “It’s pretty consistent what we’re hearing,” he said, “which is what’s out there today is not working, and people are really looking to get their arms around how do they provide alternatives to large groups and large masses of people who really haven’t had effective alternatives.” He told CNBC that JUUL will design a plan to help smokers switch from cigarettes to vaping.
JUUL added four flavors to its U.S. line of 3 percent pods yesterday, and Canadian customers also have the choice of 1.5 percent nicotine pods. JUUL appears to be putting the pieces in place to facilitate a step-down system similar to what vapers have used informally for many years. Smokers could switch to vaping with a high nicotine strength, and then lower their nicotine use in stages.
The team will target healthcare organizations and self-insured companies that are unhappy with the results of their smoking cessation plans. Those plans typically offer FDA-approved pharmaceutical products like varenicline (Chantix) and nicotine replacement therapy (NRT) products like nicotine gum, patches and lozenges.
JUUL Labs is not approved to make medical claims about its products, but that wouldn’t prevent a business from deciding to encourage employees to switch to a vapor product. JUUL is prohibited from making the claim that its products can help smokers quit.
According to a story published by CNBC, Smok the San Francisco-based vape company is building an “enterprise markets team,” led by former Cardinal Health executive Douglas Roberts, who was hired by JUUL last year. The team has 17 employees so far.
Roberts told CNBC he has spent several months meeting with employers in the public and private sectors. “It’s pretty consistent what we’re hearing,” he said, “which is what’s out there today is not working, and people are really looking to get their arms around how do they provide alternatives to large groups and large masses of people who really haven’t had effective alternatives.” He told CNBC that JUUL will design a plan to help smokers switch from cigarettes to vaping.
JUUL added four flavors to its U.S. line of 3 percent pods yesterday, and Canadian customers also have the choice of 1.5 percent nicotine pods. JUUL appears to be putting the pieces in place to facilitate a step-down system similar to what vapers have used informally for many years. Smokers could switch to vaping with a high nicotine strength, and then lower their nicotine use in stages.
The team will target healthcare organizations and self-insured companies that are unhappy with the results of their smoking cessation plans. Those plans typically offer FDA-approved pharmaceutical products like varenicline (Chantix) and nicotine replacement therapy (NRT) products like nicotine gum, patches and lozenges.
JUUL Labs is not approved to make medical claims about its products, but that wouldn’t prevent a business from deciding to encourage employees to switch to a vapor product. JUUL is prohibited from making the claim that its products can help smokers quit.
The Wall